In December 2020, PBO released a report assessing the Government of Canada’s 2018 decision to acquire, expand, operate, and eventually divest of the Trans Mountain Pipeline system.
This report provides an updated financial valuation of the purchased assets and estimates the valuation’s sensitivity to several key factors.
Regulatory changes for how the Patented Medicines Prices Review Board (PMPRB) formulates price ceilings for patented drugs have been proposed and are due to come into effect in July of 2022. This report examines the proposed change and quantifies its long-term impact. We find that a change to the median of eleven comparator countries is important, but that more flexibility to re-adjust prices would potentially contribute more to reducing expenditures by Canadians.
This report presents fiscal analysis of achieving the North Atlantic Treaty Organization’s 2% Defence Spending Target.
This report provides an estimate of the impact of the Canada Emergency Response Benefit (CERB) and the three Canada Recovery Benefits (CRBs) payments on the Canada Child Benefit (CCB) program.
This report provides current analysis of recent consumer price inflation data.
This report response to a request from the Standing Senate Committee on Official Languages to provide an independent analysis of the financial cost of Bill C-13, *An Act for the Substantive Equality of Canada's Official Languages*.